ADC Therapeutics raised €30M in a Growth/Late round in Oct 2013. The company is based in Epalinges, Switzerland. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
